CYH vs MD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
CYH
MD
Investment Advisor Scores
MD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CYH | MD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 17.6056 | 9.2937 | MD |
| PEG Ratio | 2.3833 | 0.2433 | MD |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -9.8% | 4.0% | MD |
| Earnings Growth | -75.6% | 6.5% | MD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.3/100 | 32.7/100 | CYH |
| Profit Margin | 2.1% | 9.0% | MD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | CYH |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CYH
DistributionPrice near a flattening SMA50 (slope -1.7%) with fading momentum, RSI 47
MD
MarkupPrice above SMA50, rising 50-day trend (0.6% over 20 days), RSI 66
Fundamentals Snapshot
| Metric | CYH | MD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.5 | 11.5 |
| Trailing P/E | 1.5 | 13.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.0% |
| Gross Margin | 0.4% | 0.3% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 1.85 | 2.15 |
| Dividend Yield | — | — |